# Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages

> **NCT06516016** · — · NOT_YET_RECRUITING · sponsor: **Paris Brain Institute (ICM)** · enrollment: 1000 (estimated)

## Conditions studied

- Neurodegenerative Diseases

## Interventions

- **RADIATION:** PET
- **OTHER:** MRI 3T
- **OTHER:** Oculomotricity assessment
- **OTHER:** Magnetoencephalography assessment
- **OTHER:** Body posture and gait assessment
- **OTHER:** Voice recording
- **OTHER:** Video-polysomnography
- **BIOLOGICAL:** Blood sampling, skin biopsy, excreta sampling, lumbar puncture

## Key facts

- **NCT ID:** NCT06516016
- **Lead sponsor:** Paris Brain Institute (ICM)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2034-08-31
- **Final completion:** 2034-08-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06516016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06516016, "Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06516016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*